Joann Taylor
Overview
Explore the profile of Joann Taylor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathias M, Taylor J, Mendralla E, Perez M
Antioxidants (Basel)
. 2021 Aug;
10(8).
PMID: 34439484
Bronchopulmonary dysplasia (BPD) is a common lung disease affecting premature infants that develops after exposure to supplemental oxygen and reactive oxygen intermediates. Extracellular superoxide dismutase (SOD3) is an enzyme that...
2.
Gorry P, Dunfee R, Mefford M, Kunstman K, Morgan T, Moore J, et al.
Virology
. 2007 Jan;
362(1):163-78.
PMID: 17239419
Heterozygosity for the CCR5 Delta32 allele is associated with delayed progression to AIDS in human immunodeficiency virus type 1 (HIV-1) infection. Here we describe an unusual HIV-1 isolate from the...
3.
Thomas E, Dunfee R, Stanton J, Bogdan D, Taylor J, Kunstman K, et al.
Virology
. 2006 Nov;
360(1):105-19.
PMID: 17084877
HIV infects macrophages and microglia in the central nervous system (CNS), which express lower levels of CD4 than CD4+ T cells in peripheral blood. To investigate mechanisms of HIV neurotropism,...
4.
Dunfee R, Thomas E, Gorry P, Wang J, Taylor J, Kunstman K, et al.
Proc Natl Acad Sci U S A
. 2006 Oct;
103(41):15160-5.
PMID: 17015824
HIV infects tissue macrophages and brain microglia, which express lower levels of CD4 and CCR5 than CD4+ T cells in peripheral blood. Mechanisms that enhance HIV tropism for macrophages in...
5.
Pugach P, Kuhmann S, Taylor J, Marozsan A, Snyder A, Ketas T, et al.
Virology
. 2004 Mar;
321(1):8-22.
PMID: 15033560
Primary strains of human immunodeficiency virus type 1 (HIV-1) are known to adapt to replication in cell lines in vitro by becoming sensitive to soluble CD4 (sCD4) and neutralizing antibodies...
6.
Kuhmann S, Pugach P, Kunstman K, Taylor J, Stanfield R, Snyder A, et al.
J Virol
. 2004 Mar;
78(6):2790-807.
PMID: 14990699
We have described previously the generation of an escape variant of human immunodeficiency virus type 1 (HIV-1), under the selection pressure of AD101, a small molecule inhibitor that binds the...
7.
Ohagen A, Devitt A, Kunstman K, Gorry P, Rose P, Korber B, et al.
J Virol
. 2003 Oct;
77(22):12336-45.
PMID: 14581570
The genetic evolution of human immunodeficiency virus type 1 (HIV-1) in the brain is distinct from that in lymphoid tissues, indicating tissue-specific compartmentalization of the virus. Few primary HIV-1 envelope...
8.
Molteni A, Ward W, Tsao C, Taylor J, Small Jr W, Brizio-Molteni L, et al.
Curr Pharm Des
. 2003 Feb;
9(9):751-61.
PMID: 12570792
Angiotensin converting enzyme (ACE) inhibitors and angiotensin II (AII) type 1 receptor antagonists have strong cytostatic properties on in vitro cultures of many normal and neoplastic cells. They are effective,...
9.
Gorry P, Taylor J, Holm G, Mehle A, Morgan T, Cayabyab M, et al.
J Virol
. 2002 May;
76(12):6277-92.
PMID: 12021361
Most human immunodeficiency virus type 1 (HIV-1) viruses in the brain use CCR5 as the principal coreceptor for entry into a cell. However, additional phenotypic characteristics are necessary for HIV-1...